| Literature DB >> 26231841 |
Qi-Fang Lin1, Xian-Guo Fu, Long-Teng Yao, Jing Yang, Luo-Yuan Cao, Yong-Tong Xin, Jun-Xia Hou, Lin-Feng Ye, Gen-Bin Huang.
Abstract
BACKGROUND: The purpose of this study was to investigate the association of the genotype and allele frequencies of the polymorphisms rs4379368, rs10504861, rs10915437, rs12134493 and rs13208321 in She people of China with migraine headache susceptibility. The five alleles were previously identified as being associated with migraine in a Western population, but it was not known if this association would hold in a She population. rs4379368 is in the succinic HMG coenzyme A transferase (C7orf10) gene; rs10504861 is near the matrix metallopeptidase 16 (MMP16) gene; rs10915437 is near the adherens junctions associated protein 1 (AJAP1) gene; rs12134493 is upstream of the tetraspanin 2 (TSPAN2) gene; and rs13208321 is within the four and a half LIM domains protein 5 (FHL5) gene.Entities:
Mesh:
Year: 2015 PMID: 26231841 PMCID: PMC4522003 DOI: 10.1186/s10194-015-0553-1
Source DB: PubMed Journal: J Headache Pain ISSN: 1129-2369 Impact factor: 7.277
Primers used to expansion of 5 polymorphic sites by PCR
| Polymorphisms | Primers | Sequence |
|---|---|---|
| rs4379368 | Forward | 5′-AGTGGGCTTTCATTCTGGAA-3′ |
| Reverse | 5′-AAGGGCCTGAAATCTAATTCC-3′ | |
| rs10504861 | Forward | 5′-CGTAAGAGTAATATATTGGCCCA-3′ |
| Reverse | 5′-TTCTCAATTTTGTGGTTACATGC-3′ | |
| rs10915437 | Forward | 5′-TCCTTAAGGTTCTGGCTGGGT-3′ |
| Reverse | 5′-TGGCCCTCACTAAGGGTGATT-3′ | |
| rs12134493 | Forward | 5′-TTGTTTTCTGTGCCCGACAT-3′ |
| Reverse | 5′-GAGGAAATAGAAGTGTGGGGA-3′ | |
| rs13208321 | Forward | 5′-CGCCATTTCAGAGCTGTCA-3′ |
| Reverse | 5′-TTTTGGTCATGTCCCTTCCT-3′ |
Description of sample demographic characteristics
| Migraine ( | Control ( | ||||
|---|---|---|---|---|---|
| n | % | n | % |
| |
| Gender | 0.236 | ||||
| Male | 77 | 25.7 | 90 | 30.0 | |
| Female | 223 | 74.3 | 210 | 70.0 | |
| Agea | 46.4 | 13.0 | 44.4 | 13.4 | 0.064 |
aShown as mean and standard deviation
Allele frequencies and testing for Hardy-Weinberg equilibrium of selected SNP markers
| Migraine | Control | ||||
|---|---|---|---|---|---|
| SNP | Allelea | MAFb |
| MAFb |
|
| rs4379368 | C/T (T) | 352 (58.7 %) | 0.0494c | 316 (52.7 %) | 0.5187 |
| rs10504861 | C/T (C) | 535 (89.2 %) | 0.0074c | 538 (89.7 %) | 0.0180c |
| rs10915437 | A/G (A) | 396 (66.0 %) | 0.4905 | 407 (67.8 %) | 0.1148 |
| rs12134493 | A/C (C) | 573 (95.5 %) | 0.5980 | 561 (93.5 %) | 0.2286 |
| rs13208321 | A/G (G) | 584 (97.3 %) | 0.6351 | 569 (94.8 %) | 0.1577 |
aMajor allele was indicated in parenthesis
b MAF major allele frequency; both number of the major allele and percentage in the particular group were shown
cViolation of Hardy-Weinberg equilibrium
Comparison of distribution of genotypes of selected SNP markers between migraine and control group
| All | ||||||||
|---|---|---|---|---|---|---|---|---|
| Migraine ( | Control ( | Univariate analysis | Multivariate analysisa | |||||
| SNP | n | % | n | % | OR (95 % CI) |
| ORa (95 % CI) |
|
| rs4379368 | ||||||||
| CC | 43 | 14.3 | 70 | 23.3 | 0.56 (0.34, 0.90) | 0.016 | 0.52 (0.32, 0.85) | 0.008 |
| CT | 162 | 54 | 144 | 48 | 1.02 (0.71, 1.47) | 0.923 | 0.98 (0.68, 1.43) | 0.932 |
| TT | 95 | 31.7 | 86 | 28.7 | 1.00 | 1.00 | ||
| rs10915437 | ||||||||
| GG | 32 | 10.7 | 37 | 12.3 | 0.97 (0.57, 1.65) | 0.919 | 0.98 (0.58, 1.67) | 0.948 |
| AG | 140 | 46.7 | 119 | 39.7 | 1.32 (0.94, 1.86) | 0.107 | 1.35 (0.96, 1.91) | 0.086 |
| AA | 128 | 42.7 | 144 | 48 | 1.00 | 1.00 | ||
| rs12134493b | ||||||||
| AA or AC | 26 | 8.6 | 39 | 13 | 0.64 (0.38, 1.07) | 0.090 | 0.64 (0.38, 1.08) | 0.092 |
| CC | 274 | 91.3 | 261 | 87 | 1.00 | 1.00 | ||
| rs13208321c | ||||||||
| AA or AG | 16 | 5.3 | 29 | 9.7 | 0.53 (0.28, 0.99) | 0.047 | 0.51 (0.27, 0.97) | 0.039 |
| GG | 284 | 94.7 | 271 | 90.3 | 1.00 | 1.00 | ||
OR odds ratio, CI confidence interval
aAge and gender were included as covariates
bGenotyp AA and AC were combined into one group due to small sample size
cGenotype AA and AG were combined into one group due to small sample size
Comparisons of migraine with or without aura, and controls
| Migraine | ||||||
|---|---|---|---|---|---|---|
| Aura ( | Without aura ( | Control ( | ||||
| SNP | n | % | n | % | n | % |
| rs4379368 | ||||||
| CC | 14 | 22.6 | 29 | 12.2a | 70 | 23.3b |
| CT | 37 | 59.7 | 125 | 52.5 | 144 | 48.0 |
| TT | 11 | 17.7 | 84 | 35.3 | 86 | 28.7 |
| rs10504861 | ||||||
| CC | 56 | 90.3 | 187 | 78.6 | 245 | 81.7 |
| CT | 4 | 6.5 | 45 | 18.9 | 48 | 16.0 |
| TT | 2 | 3.2 | 6 | 2.5 | 7 | 2.3 |
| rs10915437 | ||||||
| AA | 26 | 41.9 | 102 | 42.9 | 144 | 48.0 |
| AG | 30 | 48.4 | 110 | 46.2 | 119 | 39.7 |
| GG | 6 | 9.7 | 26 | 10.9 | 37 | 12.3 |
| rs12134493 | ||||||
| AA | 0 | 0.0 | 1 | 0.4 | 0 | 0.0 |
| AC | 6 | 9.7 | 19 | 8.0 | 39 | 13.0 |
| CC | 56 | 90.3 | 218 | 91.6 | 261 | 87.0 |
| rs13208321 | ||||||
| AA | 0 | 0.0 | 0 | 0.0 | 2 | 0.7 |
| AG | 1 | 1.6 | 15 | 6.3 | 27 | 9.0 |
| GG | 61 | 98.4 | 223 | 93.7 | 271 | 90.3 |
a P < 0.05 for Aura vs. Non-aura
b P < 0.05 for Non-aura vs. control